Please login to the form below

Not currently logged in

Deborah Keller appointed as chair of Fishawack Health’s board

Keller brings over three decades of experience to the position

Global healthcare communications agency Fishawack Health has announced the appointment of Deborah Keller (pictured above) as the new chair of its board.

Keller brings over three decades of experience to the role, having previously served as chief executive officer (CEO) of drug development company Covance.

Prior to taking on the CEO role at Covance, she served as group president, R&D laboratories and executive vice president at the company for almost five years.

Keller said: “The team’s exceptional expertise stood out to me. As someone who worked at the same company over a long period and eventually led the leadership team, I know how important it is to allow every employee to develop, grow and thrive. Doing so will ensure we better deliver for our clients, patients, and healthcare professionals."

Keller’s appointment follows a number of recent acquisitions at Fishawack, including the healthcare marketing and scientific communications agency The Hive Health Group and the global market access consultancy PRMA Consulting.

Article by
Lucy Parsons

8th April 2021

From: Marketing


COVID-19 Updates and Daily News

Featured jobs


Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (, a trusted independent medical website. Support the...

Latest intelligence

Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
Senior Analytics Specialist joins Research Partnership...
Digital technologies: Pharma’s answer to achieving net zero emissions?